Explore the full management transaction log of 之江生物, a listed equity based in France. Shares trade on FR FR, under the authority of AMF. Market capitalisation: €3.9bn. The latest transaction was disclosed on 5 February 2024 (Purchase). Among the most active insiders: 邵俊斌. The full history is free.